St John's wort (Hypericum perforatum L.): A review of its chemistry, pharmacology and clinical properties

Journal of Pharmacy and Pharmacology

Volumn 53, Issue 5, 2001, Pages 583-600

  Barnes, Joanne ^a   Anderson, Linda A ^b   Phillipson, J David ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRAQUINONE DERIVATIVE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIMIGRAINE AGENT; CYCLOSPORIN; DIGOXIN; FLAVONOID; FLUOXETINE; HYPERFORIN; HYPERICIN; HYPERICUM PERFORATUM EXTRACT; IMIPRAMINE; ORAL CONTRACEPTIVE AGENT; PLACEBO; PROTEINASE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; THEOPHYLLINE; TRICYCLIC ANTIDEPRESSANT AGENT; WARFARIN;

ANTIBACTERIAL ACTIVITY; ANTIVIRAL ACTIVITY; CLINICAL TRIAL; COMPARATIVE STUDY; CONFUSION; DEPRESSION; DISEASE SEVERITY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG HALF LIFE; DRUG RESEARCH; DRUG SAFETY; DRUG STRUCTURE; DRUG WITHDRAWAL; EXPERIMENTAL MODEL; GASTROINTESTINAL SYMPTOM; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERICUM PERFORATUM; META ANALYSIS; NONHUMAN; PHOTOSENSITIVITY; PHOTOTOXICITY; PHYSICAL CHEMISTRY; REVIEW; VERTIGO;

ADULT; BACTERIAL INFECTIONS; DEPRESSIVE DISORDER; DRUG INTERACTIONS; FEMALE; HUMANS; HYPERICUM; MALE; PHYTOTHERAPY; PLANTS, MEDICINAL; PREGNANCY; PREGNANCY COMPLICATIONS; RANDOMIZED CONTROLLED TRIALS; SEASONAL AFFECTIVE DISORDER; VIRUS DISEASES;

EID: 0034998557     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357011775910     Document Type: Review

References (173)

1. Agostinis, P., Vandenbogaerde, A., Donella-Deana, A., Pinna, L. A., Lee, K. T., Goris, J., Merlevede, W., Vandenheede, J. R., De Witte, P. (1995) Photosensitized inhibition of growth factor regulated protein kinases by hypericin. Biochem. Pharmacol. 49: 1615-1622
2. Albrecht, M., Hübner, W. O., Podzuweit, H., Schmidt, U. (1994) St John's wort extract in the treatment of depression: observations of the use of Jarsin capsules. Der Kassenarzt 41: 45-54
3. American Herbal Pharmacopeia (1997) St John's wort. Hypericum perforatum. Quality control, analytical and therapeutic monograph. American Botanical Council, Texas
4. Anon. (1979) Toxic reactions to plant products sold in health food stores. Med. Lett. Drugs Ther. 21: 29-30
5. Anon. (1995a) Hypericin improves blood safety? Scrip 2005: 27
6. Anon. (1995b) Hypericin HIV trial in Thailand. Scrip 2019: 25
7. Anon. (2000) CSM advice on St John's wort. Pharm. J. 264: 358
8. Ayuga, C., Rebuelta, M. (1986) A comparative study of phenolic acids of Hypericum caprifolium Boiss and Hypericum perforatum L. An. Real Acad. Farm. 52: 723-728
9. Baillie, N. (1997) Hypericum - four hypersensitivity reactions. The Modern Phytotherapist 3: 24-26
10. Ballenger, J. C., Godwin, F. K., Major, L. F., Brown, G. L. (1979) Alcohol and central serotonin metabolism in man. Arch Gen Psych Scand 57:224-227. Cited by Rezvani AH, Overstreet, D. H., Yang, Y., Clarke, E. (1999). Attenuation of alcohol intake by extract of Hypericum perforatum (St John's wort) in two different strains of alcohol-preferring rats. Alcohol Alcohol. 34: 699-705
11. Ballenger, J. C., Godwin, F. K., Major, L. F., Brown, G. L. (1979) Alcohol and central serotonin metabolism in man. Arch Gen Psych Scand 57:224-227. Cited by Rezvani AH, Overstreet, D. H., Yang, Y., Clarke, E. (1999). Attenuation of alcohol intake by extract of Hypericum perforatum (St John's wort) in two different strains of alcohol-preferring rats. Alcohol Alcohol. 34: 699-705
12. Barbenel, D. M., Yusufi, B., O'Shea, D., Bench, C. J. (2000) Mania in a patient receiving testosterone replacement post-orchidectomy taking St John's wort and sertraline. J. Psychopharmacol. 14: 84-86
13. Barnes, J., Anderson, L. A., Phillipson, J. D. (2000) Herbal medicines. A guide for health-care professionals. CD-ROM Complementary and Alternative medicine micromedex series.
14. Barone, G. W., Gurley, B. J., Ketel, B. L., Lightfoot, M. L., Abul-Ezz, S. R. (2000) Drug interaction between St John's wort and cyclosporine. Ann. Pharmacother. 34: 1013-1016
15. Beckman, S. E., Roger, W. S., Switzer, J. (2000) Consumer use of St John's wort: a survey on effectiveness, safety and tolerability. Pharmacotherapy 20: 568-574
16. Berghöfer, R., Hölzl, J. (1987) Biflavonoids in Hypericum perforatum; Part 1. Isolation of 13,II8-biapigenin. Planta Med. 53: 216-217
17. Berghöfer, R., Hölzl, J. (1989) Isolation of I3′,II8-biapigenin (amentoflavone) from Hypericum perforatum. Planta Med. 55: 91
18. Bezáková, L., Psenak, M., Kartnig, T. (1999) Effect of dianthrones and their precursors from Hypericum perforatum L. on lipoxygenase activity. Pharmazie 54: 711
19. Biber, A., Fischer, H., Romer, A., Chatterjee, S. S. (1998) Oral bioavailability of hyperforin from hypericum extracts in rats and human volunteers. Pharmacopsychiatry 31(Suppl 1): 36-43
20. Bisset, N. G. (editor). Herbal Drugs and Phytopharmaceuticals (Wichtl, M. editor, German edition). Stuttgart: Medpharm, 1994.
21. Bladt S, Wagner, H. (1994) Inhibition of MAO by fractions and constituents of Hypericum extract. J Geriatric Psychiatry Neurology 7: S57-59
22. Boblitz, N., Schrader, E., Henneicke-von Zepelin, H-H., Wüstenberg, P. (2000) Benefit of a fixed drug combination containing St John's wort and black cohosh for climacteric patients - results of a randomised clinical trial [abstract]. FACT 5: 85
23. Bombardelli, E., Morazzoni, P. (1995) Hypericum perforatum. Fitoterapia 66: 43-68
24. Bork, P. S., Bacher, S., Schmitz, M. L., Kaspers, U., Heinrich, M. (1999) Hypericin as a non-oxidant inhibitor of NF-κB. Planta Med. 65: 297-300
25. Bove, G. M. (1998) Acute neuropathy after exposure to sun in a patient treated with St John's wort. Lancet 352: 1121-1122
26. Breckenridge, A. (2000) Important interactions between St John's wort (Hypericum perforatum) preparations and prescribed medicines, http://www.open.gov.uk (accessed 29 February 2000)
27. Breidenbach, T., Hoffmann, M. W., Becker, T., Schlitt, H., Klempnauer, J. (2000) Drug interaction of St John's wort with ciclosporin. Lancet 355: 1912
28. Brenner, R., Azbel, V., Madhusoodanan, S., Pawlowska, M. (2000) Comparison of an extract of hypericum (LI160) and sertraline in the treatment of depression : a double-blind, randomized pilot study. Clin. Ther. 22: 411-419
29. Brevoort, P. (1998) The booming US botanical market. A new overview. Herbalgram 44: 33-46
30. British Herbal Pharmacopoeia (1996) Exeter: British Herbal Medicine Association
31. Brockmöller, J., Reum, T., Bauer, S., Kerb, R., Hübner, W. D., Roots, I. (1997) Hypericin and pseudohypericin : pharmacokinetics and effects on photosensitivity in humans. Pharmacopsychiatry 30(Suppl): 94-101
32. Brondz, I., Greibrokk, T., Groth, P. A., Aasen, A. J. (1982) The relative stereochemistry of hyperforin An antibiotic from Hypericum perforatum L. Tetrahedron Lett. 1 23: 1299-1300
33. Brondz, I., Greybrok, T., Aasen, A. J. (1983) n-Alkanes of Hypericum perforation: A revision. Phytochemistry 22: 295-296
34. Butterweck, V., Jurgenliemk, G., Nahrstedt, A., Winterhoff, H. (2000) Flavonoids from Hypericum perforatum show antidepressant activity in the forced swimming test. Planta Med. 66: 3-6
35. Calapai, G., Crupi, A., Firenzuoli, F., Costantino, G., Inferrera, G., Campo, G. M., Caputi, A. P. (1999) Effects of Hypericum perforatum on levels of 5-hydroxytryptamine, noradrenaline and dopamine in the cortex, diencephalon and brainstem of the rat. J. Pharm. Pharmacol. 51: 723-728
36. Chatterjee, S. S., Bhattacharya, S. K., Wonnemann, M., Singer, A., Muller, W. E. (1998a) Hyperforin as a possible antidepressant component of hypericum extracts. Life Sci. 63: 499-510
37. Chatterjee, S.S., Noldner, M., Koch, E., Erdelmeier, C. (1998b) Antidepressant activity of Hypericum perforatum and hyperforin: the neglected possibility. Pharmacopsychiatry 31(Suppl): 7-15
38. Chung, P. S., Rhee, C. K., Kim, K. H., Paek, W., Chung, J., Paiva, M. B., Eshraghi, A. A., Castro, D. J., Saxton, R. E. (2000) Intratumoral hypericin and KTP laser therapy for transplanted squamous cell carcinoma. Laryngoscope 110: 1312-1316
39. Colasanti, A., Kisslinger, A., Liuzzi, R., Quarto, M., Riccio, P., Roberti, G., Tramontane, D., Villani F. (2000) Hypericin photosensitization of tumor and metastatic cell lines of human prostate. J. Photochem. Photobiol. B. 54: 103-107
40. Colker, C. M., Kalman, D. S., Torina, G. C., Perlis, T., Street, C. (1999) Effects of Citrus aurantium extract, caffeine, and St John's wort on body fat loss, lipid levels, and mood states in overweight healthy adults. Curr. Ther. Res. 60: 145-153
41. Cooper, W. C., James, J. (1990) An observational study of the safety and efficacy of hypericin in HIV-positive subjects [abstract]. International Conference on AIDS 6: 369
42. Cott, J. M. (1997) In vitro receptor binding and enzyme inhibition by Hypericum perforatum extract. Pharmacopsychiatry 30(Suppl): 108-112
43. Council of Europe (2000) Natural sources of Flavourings. Report No. 1 Strasbourg: Council of Europe
44. Demisch, L., Hölzl, J., Golnik, B., Kacynarczyk, P. (1989) Identification of MAO-type-A inhibitors in Hypericum perforatum L. (Hyperforat). Pharmacopsychiatry 22: 194
45. De Vry, J., Maurel, S., Schreiber, R., de Beun, R., Jentzsch, K. R. (1999) Comparison of hypericum extracts with imipramine and fluoxetine in animal models of depression and alcoholism. Eur. Neuropsychopharmacol. 9: 461-468
46. De Witte, P., Agostinis, P., Van Lint J., Merlevede, W., Vandenheede, J. R. (1993) Inhibition of epidermal growth factor receptor tyrosine kinase activity by hypericin. Biochem. Pharmacol. 46: 1929-1936
47. Dorossiev, I. (1985) Determination of flavonoids in Hypericum perforatum. Pharmazie 40: 585-586
48. Durán, N., Song, P-S. (1986) Hypericin and its photodynamic action. Photochem. Photobiol. 43: 677-680
49. th Annual Meeting of the New Clinical Drug Evaluation Unit Program, Florida, US
50. Ernst, E., Rand, J. I., Barnes, J., Stevinson, C. (1998) Adverse effects profile of the herbal antidepressant St John's wort (Hypericum perforatum L.). Eur J. Clin. Pharmacol. 54: 589-594
51. European Pharmacopoeia 2000 (Suppl). Strasbourg: Masionneuve, 2000
52. European Scientific Cooperative on phytotherapy. (1996) St John's wort. Monographs on the medicinal use of plant drugs. Fascicule 1. Hyperici herba.
53. Fiebich, B., Heinrich, M., Langosch, J. M., Kammerer, N., Lieb, K. (1999) Antibacterial activity of hyperforin from St John's wort. Lancet 354: 777
54. Franklin, M., Chi, J., McGavin, C., Hockney, R., Reed, A., Campling, G., Whale, R. W., Cowan, P. J. (1999) Neuroendocrine evidence for dopaminergic actions of hypericum extract (L1 160) in healthy volunteers. Biol. Psychiatry 46: 581-584
55. Friede, M., Hasenfuss, I., Wüstenberg, P. (1998) Alltagssicherheit eines pflanzlichen Antidepressivums aus Johanniskraut. Fortschritte der Medizin 116: 31-135
56. Friede, M., Henneicke-von Zepelin, H. H., Freudenstein, J. Differential therapy of mild to moderate depressive episodes (ICD-10 F 32.0; F32.1) with Hyperici herba [abstract]. Biocenter Symposium on Drug Therapy. Pharmacology of St. John's wort (Hypericum perforatum L.) and its constituents. February 2000, Frankfurt, Germany.
57. Gambarana, C., Ghiglieri, O., Tolu, P., De Mantis, M. G., Giachetti, D., Bombardelli, E., Tagliamonte, A. (1999) Efficacy of an Hypericum perforatum (St John's wort) extract in preventing and reverting a condition of escape deficit in rats. Neuropsychopharmacology 21: 247-257
58. Garrett, B. J., Cheeke, P. R., Miranda, C. L., Goeger, D. E., Buhler, D. R. (1982) Consumption of poisonous plants (Senecio jacobaea, Symphytum officinale, Pteridium aquilinum, Hypericum perforatum) by rats: chronic toxicity, mineral metabolism, and hepatic drug-metabolizing enzymes. Toxicol. Lett. 10: 183-188
59. th Annual Meeting of the New Clinical Drug Evaluation Unit Program, Florida, US
60. Giese, A. C. (1980) Hypericism. Photochem. Photobiol. 5: 229-255
61. Gobbi, M., Valle, F. D., Ciapparelli, C., Diomede, L., Morazzoni, P., Venotta, L., Caccia, S., Cervo, L., Mennini, T. (1999) Hypericum perforatum L. extract does not inhibit 5-HT transporter in rat brain cortex. Naunyn-Schmiedebergs Arch. Pharmacol 360: 262-269
62. Gordon, J. B. (1998) SSRIs and St John's wort : possible toxicity? Am. Fam. Phys. 57: 950-953
63. Grube, B., Walper, A., Wheatley, D. (1999) St John's wort extract: efficacy for menopausal symptoms of psychological origin. Adv. Ther. 16: 177-186
64. Grube, B., Schermuck, S., Hopfenmüller, W., Michel, F. (1997) Use of a hypericum extract in mild, transient depressive mood disorders. Eur. J. Clin. Res. 9: 293-302
65. Grujic-Vasic, J., Bosnić, T., Jovanović, M. (1986) The examining of isolated tannins and their astringent effect. Planta Med 52 (Suppl.): 67-68
66. Grush, L. R., Nierenberg, A., Keefe, B., Cohen, L. S. (1998) St John's wort during pregnancy. J. Am. Med. Assoc. 280: 1566
67. Gulick, R. M., McAuliffe, V., Holden-Wiltse, J., Crumpacker, C., Liebes, L., Stein, D. S., Meehan, P., Hussey, S., Forcht, J. (1999) Phase I studies of hypericin, the active compound in St John's wort, as an antiretroviral agent in HIV-infected adults. Ann. Intern. Med. 130: 510-514
68. Harrer, G., Schmidt, U., Kuhn, U., Biller, A. (1999) Comparison of equivalence between the St John's wort extract LoHyp-57 and fluoxetine. Arzneim-Forsch 49: 289-296
69. Helgason, C. M., Frank, J. L., Johnson, D. R., Frank, M. G., Hendricks, S. E. (2000) The effects of St John's wort (Hypericum perforatum) on NK cell activity in vitro. Immunopharmacology 46: 247-251
70. Hoelzl, J., Ostrowski, E. (1987) St John's wort (Hypericum perforatum L.). HPLC analysis of the main components and their variability in a population. Deutsch Apoth Ztg 127: 1227-1230
71. Holsboer-Trachsler, E., Henauer, S., Vanoni, C. H. (1999) Efficacy and tolerability of the hypericum special extract LI 160 in young and elderly outpatients with depressive disorders: a drug monitoring study. Eur Neuropsychopharmacology 9(Suppl 5): S226
72. Hottenrot, K., Sommer, H-M., Lehrl, S., Hauer, H. (1997) The influence of vitamin E and extract from hypericum on the endurance capacity of competitors. A placebo-controlled double-blind study with long-distance runners and triathletes. Deutsche seitschrift für Sportmedizin 48: 22-27
73. Hudson, J. B., Lopez-Bazzocchi, I., Towers, G. H. (1991) Antiviral activities of hypericin. Antiviral Res 15: 101-112
74. Hypericin - a plant extract with anti-HIV activity. Scrip 1989; 1415: 29
75. Isenberg, L. (1998) Herbal products are driving supplement industry growth. Herbalgram 42: 65
76. Johne, A., Brockmoller, J., Bauer, S., Maurer, A., Langheinrich, M., Roots, I. (1999) Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum). Clin. Pharmacol. Ther. 66: 338-345
77. Johnston, N. (1999) Sun trap. New Scientist July 24:24
78. Kalb, R., Trautman-Sponsel, R. D., Klement, S. Hypericum extract WS 5572 is effective and safe in the treatment of mild to moderate depression [abstract]. Biocenter Symposium on Drug Therapy. Pharmacology of St. John's wort (Hypericum perforatum L.) and its constituents. February 2000, Frankfurt, Germany.
79. Kamuhabwa, A. R., Geboes, K. R., de Witte, P. A. (2000a) Investigation of the absorption of hypericin into the skin of hairless mice. J. Pharm. Pharmacol. 52: 487-494
80. Kamuhabwa, A. R., Agostinis, P., D'Hallewin, M. A., Kasran, A., de Witte, P. A. (2000b) Photodynamic activity of hypericin in human urinary bladder carcinoma cells. Anticancer Res. 20: 2579-2584
81. Kasper, S. (1997) Treatment of seasonal affective disorder (SAD) with hypericum extract. Pharmacopsychiatry 30(Suppl): 89-93
82. Käufeler, R., Meier, B., Brattström, A. Efficacy and tolerability of the St John's wort extract (Ze 117) in comparison with placebo, imipramine and fluoxetine for the treatment of mild to moderate depression according to ICD-10 [abstract]. Biocenter Symposium on Drug Therapy. Pharmacology of St. John's wort (Hypericum perforatum L.) and its constituents. February 2000, Frankfurt, Germany.
83. Kerb, R., Bayer, S., Brockmöller, J., Roots, I. (1997) Urinary 6-beta-hydroxycortisol excretion rate is affected by treatment with hypericum extract. Eur. J. Clin. Pharmacol. 52: 607
84. Kim, H. L., Streltzer, J., Goebert, D. (1999) St John's wort for depression. A meta-analysis of well-defined clinical trials. J. Nerv. Ment. Dis. 187: 532-539
85. Koch, E., Chatterjee, S. S. (2000) Hyperforin stimulates intracellular calcium mobilisation and enhances extracellular acidification in DDT1-MF2 smooth muscle cells [abstract], Biocenter Symposium on Drug Therapy. Pharmacology of St. John's wort (Hypericum perforatum L.) and its constituents. Frankfurt, Germany.
86. Kumar, V., Singh, P. N., Muruganandam, A. V., Bhattacharya, S. K. (2000) Effect of Indian Hypericum perforatum Linn on animal models of cognitive dysfunction. J. Ethnopharmacol. 72: 119-128
87. Laakman, G., Schüle, C., Dienel, A. (2000) Effects of hypericum extract on adenohypophysial hormone secretion and catecholamine metabolism [abstract]. Biocenter Symposium on Drug Therapy. Pharmacology of St. John's wort (Hypericum perforatum L.) and its constituents. Frankfurt, Germany.
88. Laakmann, G., Schüle, C., Baghai, T., Kieser, M. (1998) St John's wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy. Pharmacopsychiatry 31(Suppl): 54-59
89. Lane-Brown, M. M. (2000) Photosensitivity associated with herbal preparations of St John's wort (Hypericum perforatum). Med J Aust 172: 302
90. Lantz, M. S., Buchalter, E., Giambano, V. (1999) St John's wort and antidepressant drug interactions in the elderly. J. Geriatr. Psychiatry Neurol. 12: 7-10
91. Lavie, G., Valentine, F., Levin, B., Mazur, Y., Gallo, G., Lavie, D., Weiner D., Meruelo, D. (1989) Studies of the mechanisms of the antiretroviral agents hypericin and pseudohypericin. Proc. Natl Acad. Sci. 86: 5963-5967
92. Lemmer, W., von den Driesch, V., Klieser, E. (1999) Wirksamkeit im Alter und bei chronischen Verlaufsformen. Münch Med Wschr Fortschr Med. 141: 43
93. Lenoir, S., Degenring, F. H., Saller, R. (1999) A double-blind randomised trial to investigate three different concentrations of a standardised fresh plant extract obtained from the shoot tips of Hypericum perforatum L., Phytomedicine 6: 141-146
94. Linde, K., Berner, M. (1999) Commentary: Has hypericum found its place in antidepressant treatment? BMJ 319: 1539
95. Linde, K., Mulrow, C. D. (2001) St John's wort for depression (Cochrane Review). In: The Cochrane Library. Issue 1, Oxford: Update Software
96. Linde, K., Ramirez, G., Mulrow, C. D., Pauls, A., Weidenhammer, W., Melchart, D. (1996) St John's wort for depression - an overview and meta-analysis of randomised clinical trials. BMJ 313: 253-258
97. Liu, C. D., Kwan, D., Saxton, R. E., McFadden, D. W. (2000) Hypericin and photodynamic therapy decreases human pancreatic cancer in vitro and in vivo. J. Surg. Res. 93: 137-143
98. Lopez-Bazzocchi, I., Hudson, J. B., Towers, G. H. (1991) Antiviral activity of the photoactive plant pigment hypericin. Photochem. Photobiol. 54: 95-98
99. Markowitz, J. S., Devane, C. L., Boulton, D. W., Carson, S. W., Nahas, Z, Risch, S. C. (2000) Effect of St John's wort (Hypericum perforatum) on cytochrome P450 2D6 and 3A4 activity in healthy volunteers. Life Sci. 66: 133-139
100. Mathis, C., Ourisson, G. (1964a) Étude chimio-taxonomique du genre Hypericum - II. Identification de constituants de diverses huiles essentielles d'Hypericum. Phytochemistry 3: 115-131
101. Mathis, C., Ourisson, G. (1964b) Étude chimio-taxonomique du genre Hypericum - IV. Repartition des sesquiterpenes, des alcools monoterpeniques et des aldehydes satures dans les huiles essentielles d'Hypericum. Phytochemistry 3: 377-378
102. Mathis, C., Ourisson, G. (1964e) Étude chimio-taxonomique du genre Hypericum - V. Identification de quelques constituants non volatils d'Hypericum perforatum L. Phytochemistry 3: 379
103. Maurer, A., Johne, A., Bauer, S., Brockmöller, J., Donath, F., Roots, I., Langheinrich, M., Hübner, W-D. (1999) Interaction of St John's wort extract with phenprocoumon [abstract]. Eur. J. Clin. Pharmacol. 55: A22
104. Meier, B., Liske, E., Rosinus, V. (1997) Wirksamkeit und Verträglichkeit eines standardisierten Johanniskraut-Vollextraktes (Ze 117) bei Patienten mit depressiver Symptomatik unterschiedlicher Schweregrade eine Anwendungsbeobachtung. Forsch Komplementärmed 4: 87-93
105. Melzer, R., Fricke U, Holz, J. (1988) Proanthocyanidins from Hypericum perforatum: Effects on isolated pig coronary arteries. Planta Med. 54: 572-573
106. Meruelo, D., Lavie, G., Lavie, D. (1988) Therapeutic agents with dramatic antiretroviral activity and little toxicity at effective doses: aromatic polycyclic diones hypericin and pseudohypericin. Proc. Natl Acad. Sci. 85: 5230-5234
107. Mills, S., Bone, K. (2000) Principles and Practice of Phytotherapy, Edinburgh: Churchill Livingstone
108. Mishenkova, E. L., Derbentseva, N. A., Garagulva, A. D., Litvin, L. N. (1975) Antiviral properties of St John's wort and preparations produced from it. Tr S'ezda Mikrobiol Ukr 222-322
109. Moore, L. B., Goodwin, B., Jones, S. A., Wisely, G. B., Serabjit-Singh, C. J., Willson, T. M., Collins, J. L., Kliewer, S. A. (2000) St John's wort induces hepatic drug metabolism through activation of the pregnane X receptor. Proc. Natl Acad. Sci. 97: 7500-7502
110. Mueller, B. M. (1998a) Effects of hypericum extract HYP811 in patients with psychovegetative disorders. Adv. Ther. 15: 255-260
111. Mueller, B. M. (1998b) St John's wort for depressive disorders: results of an outpatient study with the hypericum preparation HYP811. Adv. Ther. 15: 109-116
112. Müller, W. E., Rolli, M., Schafer, C., Hafner, U. (1997) Effects of hypericum extract (LI 160) in biochemical models of antidepressant activity. Pharmacopsychiatry 30(Suppl): 102-107
113. Nahrstedt, A., Butterweck, V. (1997) Biologically active and other chemical constituents of the herb of Hypericum perforatum L. Pharmacopsychiatry 30(Suppl): 129-134
114. Nathan, P. J. (1999) The experimental and clinical pharmacology of St John's Wort (Hypericum perforatum L). Molecular Psychiatry 4: 333-338
115. Nebel, A., Schneider, B. J., Baker, R. K., Kroll, D. J. (1999) Potential metabolic interaction between St John's wort and theophylline. Ann. Pharmacother. 33: 502
116. Newall, C. A., Anderson, L. A., Phillipson, J. D. (1996) Herbal Medicines. A Guide for Health-care Professionals. 1st edn. London: Pharmaceutical Press
117. Nierenberg, A. A., Burt, T., Matthews, J., Weiss, A. P. (1999) Mania associated with St John's wort. Biol. Psychiatry 46: 1707-1708
118. O'Breasil, A. M., Argouarch, S. (1998) Hypomania and St John's wort. Can. J. Psychiatry 43: 746-747
119. Obach, R. S. (2000) Inhibition of human cytochrome P450 enzymes by constituents of St John's wort, an herbal preparation used in the treatment of depression. J. Pharmacol. Exp. Ther. 294: 88-95
120. Ollivier, B., Balansard, G., Maillard, C., Vical, E. (1985) Separation et identification des acides phenols par chromatographie liquide haute performance et spectroscopie ultra-violette. Application à la pariétaire (Parietaria officinalis L.) et au millepertuis (Hypericum perforatum L.). J. Pharm. Belg. 40: 173-177
121. Ondrizek, R. R., Chan, P. J., Patton, W. C., King, A. (1999) Inhibition of human sperm motility by specific herbs used in alternative medicine. J. Assist. Reprod. Genet. 16: 87-91
122. Panocka, I., Perfumi, M., Angeletti, S., Ciccocioppo, R., Massi, M. (2000) Effects of Hypericum perforatum on ethanol intake, and on behavioural despair: a search for the neurochemical systems involved. Pharmacol. Biochem. Behav. 66: 105-111
123. Panossian, A. G., Gabrielian, E., Manvelian, V., Vulcic, K., Wagner, H. (1996) Immunosuppressive effects of hypericin on stimulated human leucocytes : inhibition of the arachidonic acid release, leukotriene B4 and interleukin-1 production and activation of nitric oxide formation. Phytomedicine 3: 19-28
124. Parfitt, K., ed. (1999) Martindale The Complete Drug Reference. 32nd edn. London: Pharmaceutical Press
125. Philipp, M., Kohnen, R., Hiller, K. O. (1999) Hypericum extract versus imipramine or placebo in patients with moderate depression: randomised multicentre study of treatment for eight weeks. BMJ 319: 1534-1539
126. Piscitelli, S., Burstein, A. H., Chaitt, D., Alfaro, R. M., Falloon, J. (2000) Indinavir concentrations and St John's wort. Lancet 335: 547-548
127. Pitisuttithum, P., Migasena, S., Suntharasamai, P. International Conference on AIDS 1996;11(1):285. Cited by Mills & Bone 2000
128. Rey, J., Walter, G. (1998) Hypericum perforatum (St John's wort) in depression: pest or blessing? Med. J. Aust. 169: 583-586
129. Rezvani, A. H., Overstreet, D. H., Yang, Y., Clarke, E. (1999) Attenuation of alcohol intake by extract of Hypericum perforatum (St John's wort) in two different strains of alcohol-preferring rats. Alcohol Alcohol. 34: 699-705
130. Roby, C. A., Anderson, G. D., Kantor, E., Dryer, D. A., Burstein, A. H. (2000) St John's wort : effect on CYP3A4 activity. Clin. Pharmacol. Ther. 67: 451-457
131. Ruschitzka, F., Meier, P. J., Turina, M., Luscher, T. F., Noll, G. (2000) Acute heart transplant rejection due to Saint John's wort. Lancet 355: 548-549
132. Schellenberg, R., Sauer, S., Dimpfel, W. (1998) Pharmacodynamic effects of two different hypericum extracts in healthy volunteers measured by quantitative EEG. Pharmacopsychiatry 31(Suppl): 44-53
133. Schempp, C., Winghofer, B., Langheinrich, M., Schopt, E., Simon, J. C (1999a) Hypericin levels in human serum and interstitial skin blister fluid after oral single-dose and steady-state administration of Hypericum perforatum extract (St John's wort). Skin Pharmacol. Appl. Skin Physiol. 12: 299-304
134. Schempp, C., Pelz, K., Wittmer, A., Schopf, E., Simon, J. C. (1999b) Antibacterial activity of hyperforin from St John's wort, against multiresistant Staphylococcus aureus and gram-positive bacteria. Lancet 353: 2129
135. Schempp, C. M., Winghofer, B., Ludtke, R., Simon-Haarhuis, B., Schopf, E., Simon, J. C. (2000a) Topical application of St John's wort (Hypericum perforatum L.) and of its metabolite hyperforin inhibits the allostimulatory capacity of epidermal cells. Jr. J. Dermatol. 142: 979-984
136. Schempp, C. M., Ludtke, R., Winghofer, B., Simon, J. C. (2000b) Effect of topical application of Hypericum perforatum extract (St John's wort) on skin sensitivity to solar simulated radiation. Photodermatol. Photoimmunol. Photomed. 16: 125-128
137. Schey, K. L., Patat, S., Chignell, C. F., Datillo, M., Wang, R. H., Roberts, J. E. (2000) Photooxidation of lens alpha-crystallin by hypericin. Photochem. Photobiol. 72: 200-203
138. Schneck, C. (1998) St John's wort and hypomania. J. Clin. Psychiatry 59: 689
139. Schrader, E. (2000) Equivalence of St John's wort extract (Ze 117) and fluoxetine: a randomized, controlled study mild-moderate depression. Int. J. Clin. Psychopharmacol. 15: 61-68
140. Schrader, E., Meier, B., Brattström, A. (1998) Hypericum treatment of mild-moderate depression in a placebo-controlled study. A prospective, double-blind, randomized, placebo-controlled, multicentre study. Human Psychopharmacol. 13: 163-169
141. Schulz, V., Hänsel, R., Tyler, V. (1998) Rational Phytotherapy. A Physicians' Guide to Herbal Medicine. Berlin: Springer-Verlag
142. Sharpley, A. L., McGavin, C. L., Whale, R., Cowen, P. J. (1998) Antidepressant-like effect of Hypericum perforatum (St John's wort) on the sleep polysomnogram. Psychopharmacology 139: 286-287
143. Shiplochliev, T. (1981) Extracts from a group of medicinal plants enhancing the uterine tonus. Vet Med Nauki 18: 94-98
144. Shipochliev, T., Dimitrov, A., Aleksandrava, E. (1981) Anti-inflammatory action of a group of plant extracts. Vet. Med. Nauki. 18: 87-94
145. Siegers, C., Biel, S., Wilhelm, K-P. (1993) Zur Frage der Phototoxizität von Hypericum. Nervenheilkunde 12: 320-322
146. +. J. Pharmacol. Exp. Ther. 290: 1363-1368
147. + concentration in human platelets [abstract]. Biocenter Symposium on Drug Therapy. Pharmacology of St. John's wort (Hypericum perforatum L.) and its constituents. February 2000, Frankfurt, Germany.
148. Staffeldt, B., Kerb, R., Brockmoller, J., Ploch, M., Roots, I. (1994) Pharmacokinetics of hypericin and pseudohypericin after oral intake of the Hypericum perforatum extract LI 160 in healthy volunteers. J. Geriatr. Psychiatry Neurol. 7: S47-53
149. Steinbeck-Klose, A., Wernet, P. (1993) Successful long-term treatment over 40 months of HIV-patients with intravenous hypericin [abstract]. International Conference on AIDS 9: 470
150. Stevinson, C., Ernst E. (1999) Safety of hypericum in patients with depression. A comparison with conventional antidepressants. CNS Drugs 11: 125-132
151. Stevinson, C., Ernst, E. (2000) A pilot study of Hypericum perforatum, for the treatment of premenstrual syndrome. Br. J. Obstet. Gynaecol. 107: 870-876
152. Stevinson, C., Dixon, M., Ernst, E. (1998) Hypericum for fatigue a pilot study. Phytomedicine 5: 443-447
153. Suzuki, O., Katsumata, Y., Oya, M., Bladt, S., Wagner, H. (1984). Inhibition of monoamine oxidase by hypericin. Planta Med. 50: 272-274
154. Tahara, Y. R., Sakamoto, T. R., Oshima, Y. R., Ishibashi, T. R., Inomata, H. R., Murata, T. R., Hinton, D. R., Ryan, S. J. (1999) The antidepressant hypericin inhibits progression of experimental proliferative vitreoretinopathy. Curr. Eye Res. 19: 323-329
155. Takahashi, I., Nakanishi, S., Kobayashi, E., Nakano, H., Suzuki, K., Tamaoki, T. (1989) Hypericin and pseudohypericin specifically inhibit protein kinase C: possible relation to their antiretroviral activity. Biochem. Biophys. Res. Comm. 165: 1207-1212
156. Taylor, L. H., Kobak, K. A. (2000) An open-label trial of St John's wort (Hypericum perforatum) in obsessive-compulsive disorder. J. Clin. Psychiatry 61: 575-578
157. Thiede, H. M., Walper, A. (1994) Inhibition of MAO and COMT by Hypericum extracts and hypericin. J. Ger. Psychiatry Neurol. 7: S54-56
158. Trifunovic, S., Vajs, V., Macura, S., Juranic, N., Djarmati, Z., Jankov, R., Milosavljevic, S. (1998) Oxidation products of hyperforin from Hypericum perforatum. Phytochemistry 49: 1305-1310
159. Uebelhack, R., Franke, L. (2000) In vitro effects of hypericum extract and hyperforin on 5HT uptake and efflux in human blood platelets [abstract]. Biocenter Symposium on Drug Therapy. Pharmacology of St. John's wort (Hypericum perforatum L.) and its constituents. Frankfurt, Germany.
160. Vandenbogaerde, A., Zandi, P., Puia, G., Truzzi, C., Kamuhabwa, A., de Witte, P., Merlevede, W., Baraldi, M. (2000) Evidence that total extract of Hypericum perforatum affects exploratory behaviour and exerts anxiolytic effects in rats. Pharmacol. Biochem. Behav. 65: 627-633
161. Vanhaelen, M., Vanhaelen-Fastre, R. (1983) Quantitative determination of biologically active constituents in medicinal plant crude extracts by thin-layer chromatography-densitometry. J. Chromatogr. 281: 263-271
162. Verotta, L., Appendino, G., Belloro, E., Jakupovic, J., Bombardelli, E. (1999) Furohyperforin, a prenylated phloroglucinol from st. John's wort (Hypericum perforatum). J. Nat. Prod. 62: 770-772
163. Verotta, L., Appendino, G., Jakupovic, J., Bombardelli, E. (2000) Hyperforin analogues from St John's wort (Hypericum perforatum). J. Nat. Prod. 63: 412-415
164. Vitiello, B. (1999) Hypericum perforatum extracts as potential antidepressants. J. Pharm. Pharmacol. 51: 513-517
165. Voss, A., Verweij, P. E. (1999) Antibacterial activity of hyperforin from St John's wort. Lancet 354: 777
166. Weber, N. D., Murray, B. K., North, J. A., Wood, S. G. (1994) The antiviral agent hypericin has in vitro activity against HSV-1 through non-specific association with viral and cellular membranes. Antiviral Chemistry & Chemotherapy 5: 83-90
167. Wheatley, D. (1999) Hypericum in seasonal affective disorder (SAD). Curr. Med. Res. Opin. 15: 33-37
168. Woelk, H. (2000) Comparison of St John's wort and imipramine for treating depression : randomised controlled trial. BMJ 321: 536-539
169. Woelk, H., Burkard, G., Grunwald, J. (1994) Benefits and risks of the hypericum extract LI 160. Drug monitoring study with 3250 patients. J. Geriatr. Psychiatry Neurol. 7(Suppl. 1): 34-38
170. Wonnemann, M., Singer, A., Muller, W. E. (2000) Inhibition of synaptosomal uptake of 3H-L-glutamate and 3H-GABA by hyperforin, a major constituent of St John's wort: the role of amiloride sensitive sodium conductive pathways. Neuropsychopharmacology 23: 188-197
171. Wood, S, Huffman, J., Weber, N., Andersen, D., North, J., Murray, B., Sidwell, R., Hughes, B. (1990) Antiviral activity of naturally occurring anthraquinones and anthraquinone derivatives. Planta Med. 56: 651-652
172. Yu, P. H. (2000) Effect of the Hypericum perforatum extract on serotonin turnover in the mouse brain. Pharmacopsychiatry 33: 60-65
173. Yue, Q-Y., Bergquist, C., Gerden, B. (2000) Safety of St John's wort (Hypericum perforatum). Lancet 355: 576-577